Brainstorm Cell Therapeutics Inc. - Common Stock (BCLI)
1.1700
-0.0700 (-5.65%)
NASDAQ · Last Trade: May 21st, 10:50 AM EDT
Which stocks have an unusual volume on Tuesday?
Via Chartmill · May 20, 2025
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.
Via Chartmill · May 20, 2025
Via Benzinga · May 20, 2025
BrainStorm Cell Therapeutics plans to enroll 200 ALS patients in its FDA-cleared Phase 3b trial of NurOwn, with a 24-week double-blind phase followed by an open-label extension.
Via Stocktwits · May 19, 2025

Brainstorm Cell just reported results for the first quarter of 2024.
Via InvestorPlace · May 14, 2024
Let's have a look at what is happening on the US markets on Monday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · May 19, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · May 19, 2025
Via Benzinga · April 30, 2025
Unusual volume stocks in Friday's session
Via Chartmill · April 11, 2025
Via Benzinga · April 10, 2025
Via Benzinga · April 10, 2025
Via Benzinga · April 4, 2025
Via Benzinga · March 19, 2025

Via Benzinga · September 27, 2024

BCLI stock results show that Brainstorm Cell missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 14, 2024

Via Benzinga · June 14, 2024

Via Benzinga · June 10, 2024

Via Benzinga · May 24, 2024

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news for Wednesday morning!
Via InvestorPlace · May 1, 2024

Via Benzinga · April 30, 2024